UCBJF Overview
Upcoming Projects (UCBJF)
-
Don’t see a project related to the company you care about? Create your own!
Executed Projects (UCBJF)
-
Discussing UCB's (Neurona Therapeutics) NRTX-1001 (Allogeneic Cell Therapy) for Drug-Resistant Epilepsy and the Phase 1/2 Data Presented at AAN 2026
Tickers: UCBJF, Neurona Therapeutics, NVS, ABT, JNJ, PFE, ESALF, JAZZ, SNY
Executed On: Apr 23, 2026 at 06:00 PM EDT -
Discussing the potential of fenfluramine from UCB for patients with CDKL5 Deficiency Disorder and Epilepsy.
Ticker: UCBJF
Executed On: Aug 26, 2025 at 11:00 AM EDT -
Understand early perceptions UCB's UCB0022 asset for the treatment of Parkinson's Disease.
Tickers: UCB.XBRU, UCBJF, UNC.XFRA, 0NZT.XLON
Executed On: Feb 01, 2024 at 03:00 PM EST
Upcoming & Overdue Catalysts (UCBJF)
-
Don’t see a catalyst related to the company you care about? Create your own!
Strategic Initiatives (UCBJF)
-
Don’t see a strategic initiative related to the company you care about? Create your own!
